Clene Nanomedicine to Present at Upcoming Investor Conferences

Rhea-AI Summary

Clene Inc. (NASDAQ: CLNN), a biopharmaceutical company focused on treating neurodegenerative diseases, announced its participation in several upcoming healthcare conferences. Key events include the Roth 34th Annual Healthcare Conference on March 14, 2022, and the Oppenheimer 32nd Annual Healthcare Conference on March 15, 2022, with respective presentation times of 3:00 PM ET and 8:40 AM ET. Webcasts will be available for on-demand viewing on the company's website. Clene aims to revolutionize treatments targeting energetic failure in neurological diseases.

SALT LAKE CITY, March 03, 2022 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ: CLNN) along with its subsidiaries “Clene” and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative disease, today announced that Clene will participate in the following upcoming conferences:

• Roth 34^th Annual Healthcare Conference, March 14, 2022
  Presentation Time: 3:00 pm ET
  Webcast link: https://wsw.com/webcast/roth43/clnn/1822892

• Oppenheimer 32^nd Annual Healthcare Conference, March 15, 2022
  Presentation Time: 8:40 am ET
  Webcast link: https://wsw.com/webcast/oppenheimer20/clnn/2765322

• Maxim Group Emerging Growth Conference, March 28, 2022
  Presentation Time: 5:00 pm ET
  

Live audio webcasts will be available for on-demand viewing for the Roth and Oppenheimer Conferences and will be available on the Investors section of the company’s website at www.clene.com. A replay will be available after the events and archived on the website for 90 days.

About Clene
Clene is a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative disease by targeting energetic failure, an underlying cause of many neurological diseases. The company is based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland. For more information, please visit www.clene.com or follow us on Twitter, LinkedIn and Facebook.

Media Contact
Erica Fiorini, Ph.D., or David Schull
Russo Partners, LLC
Erica.fiorini@russopartnersllc.com
David.schull@russopartnersllc.com
+1-212-845-4253

Investor Contact
John Woolford
Managing Director, Westwicke
clene@westwicke.com
+1-443-213-0506

FAQ

What conferences will Clene Inc. (CLNN) participate in March 2022?

Clene Inc. will participate in the Roth 34th Annual Healthcare Conference on March 14, 2022, and the Oppenheimer 32nd Annual Healthcare Conference on March 15, 2022.

What is the presentation schedule for Clene Inc. (CLNN) at the healthcare conferences?

Clene will present at the Roth Conference at 3:00 PM ET and at the Oppenheimer Conference at 8:40 AM ET.

Where can I watch Clene Inc.'s (CLNN) conference presentations?

The live audio webcasts will be available on Clene's website for on-demand viewing after the events.

What is Clene Inc.’s (CLNN) focus in the biopharmaceutical industry?

Clene focuses on revolutionizing treatments for neurodegenerative diseases by targeting energetic failure.